EIDX - Eidos Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - EIDX (1731831)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
28 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2019-07-10
EIDXSiu ChristineCFO, SecretaryS - Sale+OE$39.37-5,00036,470-12%-$196,850
2019-07-03
EIDXSatvat Ali J.Dir, 10%P - Purchase$29.90+882,35324,575,501+4%+$26,382,796
2019-07-03
EIDXKumar NeilCEO, 10%P - Purchase$29.90+882,35324,575,501+4%+$26,382,796
2019-07-03
EIDXAguiar EricDir, 10%P - Purchase$29.90+882,35324,575,501+4%+$26,382,796
2019-07-03
EIDXBridgebio Pharma, Inc.10%P - Purchase$29.90+882,35324,575,501+4%+$26,382,796
2019-06-05
EIDXSiu ChristineCFO, SecretaryS - Sale$29.97-17,00019,470-47%-$509,487
2019-06-04
EIDXTurtle CameronChief Business OfficerS - Sale$31.64-10,000100,155-9%-$316,402
2019-05-30
EIDXFox Jonathan CSee RemarksS - Sale$32.64-5,000516,527-1%-$163,179
2019-05-24
EIDXSatvat Ali J.Dir, 10%P - Purchase$25.93+1,103,84823,693,148+5%+$28,622,779
2019-05-24
EIDXKumar NeilCEO, 10%P - Purchase$25.93+1,103,84823,693,148+5%+$28,622,779
2019-05-24
EIDXAguiar EricDir, 10%P - Purchase$25.93+1,103,84823,693,148+5%+$28,622,779
2019-05-24
EIDXBridgebio Pharma, Inc.10%P - Purchase$25.93+1,103,84823,693,148+5%+$28,622,779
2019-05-23
EIDXSinha UmaChief Scientific OfficerS - Sale$27.28-5,000349,312-1%-$136,376
2019-05-03
EIDXFox Jonathan CSee RemarksS - Sale$25.03-5,000521,527-1%-$125,150
2019-05-01
EIDXFox Jonathan CSee RemarksS - Sale$25.46-5,000527,608-1%-$127,287
D
2019-04-24
EIDXSiu ChristineCFO, SecretaryS - Sale+OE$26.11-5,00034,701-13%-$130,550
2019-04-15
EIDXFox Jonathan CSee RemarksS - Sale$23.11-5,000531,527-1%-$115,550
D
2019-03-19
EIDXSiu ChristineCFO, SecretaryS - Sale+OE$19.66-11,91334,701-26%-$234,210
A
2018-12-10
EIDXBridgebio Pharma LLC10%P - Purchase$13.33+40,65322,589,3000%+$542,063
AM
2018-12-06
EIDXBridgebio Pharma LLC10%P - Purchase$13.67+80,14422,548,6470%+$1,095,867
2018-12-10
EIDXBridgebio Pharma LLC10%S - Sale$13.33-40,65322,589,3000%-$542,063
M
2018-12-06
EIDXBridgebio Pharma LLC10%S - Sale$13.67-80,14422,548,6470%-$1,095,867
M
2018-12-03
EIDXBridgebio Pharma LLC10%P - Purchase$14.92+2,853,84822,468,503+15%+$42,589,910
D
2018-06-22
EIDXBridgebio Pharma LLC10%P - Purchase$17.00+1,000,00019,614,655+5%+$17,000,000
D
2018-06-22
EIDXRa Capital Management, LLCDirP - Purchase$17.00+1,058,8242,162,671+96%+$18,000,008
D
2018-06-22
EIDXShah Rajeev M.DirP - Purchase$17.00+1,058,8242,162,671+96%+$18,000,008
D
2018-06-22
EIDXKumar NeilCEO, 10%P - Purchase$17.00+1,000,00019,614,655+5%+$17,000,000
D
2018-06-22
EIDXSatvat Ali J.Dir, 10%P - Purchase$17.00+1,000,00019,614,655+5%+$17,000,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top